Ruxandra Draghia-Akli - 11 Nov 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Stock Option (Right to Buy)	Award	$577,992	+64,150		$9.01	64,150	11 Nov 2024	Common Stock	64,150	$9.01	Direct	F1
transaction	NVAX	Restricted Stock Units	Award	$0	+42,770		$0.000000	42,770	11 Nov 2024	Common Stock	42,770		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F3	One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.